MELISSA BAKER: Open Payments
NPI 1861443384 · CLARKSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$194 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $71 · 2025 $194
Food & beverage: $194
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $75 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Boston Scientific Corporation | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Biogen, Inc. | 1 | $20 |
| Indivior Inc. | 1 | $15 |
Products named: Rybelsus, Wegovy, BodyGuardian, FANAPT, BEXSERO, ZURZUVAE, TRELEGY ELLIPTA, Ozempic.
Industry payments across KY — which companies pay providers there.
